Comparative Evaluation of Alternative Methods for Broth Dilution Susceptibility Testing of Fluconazole Against Candida Albicans
Overview
Authors
Affiliations
A comparative evaluation of methods for broth macro- and microdilution susceptibility testing of fluconazole was conducted with 119 clinical isolates of Candida albicans. Macro- and microdilution testing were performed according to National Committee for Clinical Laboratory Standards recommendations. For reference macrodilution testing, an 80% inhibition endpoint (MIC 80%) was determined after 48 h of incubation in accordance with National Committee for Clinical Laboratory Standards proposed standard M27-P. Microdilution endpoints were scored as the first tube or well in which a prominent reduction in turbidity (score 2 out of a possible 4) was observed compared with the growth control (Micro MIC-2). Alternative endpoint criteria were assessed independently of the reference MIC 80% and Micro MIC-2 values and included a colorimetric microdilution endpoint determined by using an oxidation-reduction indicator (Alamar Blue; Alamar Bio-sciences Inc., Sacramento, Calif.). The MICs for the two microdilution test systems were read after 24 and 48 h of incubation. The percentage of fluconazole MICs within 2 doubling dilutions of the macrodilution reference values was 94% for both microdilution tests read at 24 h. Agreement was slightly lower at 48 h and ranged from 91 to 93%. Comparison of Micro MIC-2 and colorimetric microdilution MICs resulted in agreements of 97 and 93% at 24 and 48 h, respectively. These results show excellent agreement among alternative methods for fluconazole susceptibility testing.
Osmani Z, Islam M, Wang F, Meira S, Kulka M Plant Methods. 2024; 20(1):165.
PMID: 39472941 PMC: 11523603. DOI: 10.1186/s13007-024-01289-x.
Brouwer C, Boekhout T, Alwasel S, Rahman M, Janga R, Welling M Am J Transl Res. 2024; 16(2):669-680.
PMID: 38463589 PMC: 10918136.
Revisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon.
Lavogina D, Lust H, Tahk M, Laasfeld T, Vellama H, Nasirova N Biosensors (Basel). 2022; 12(4).
PMID: 35448256 PMC: 9032648. DOI: 10.3390/bios12040196.
A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance.
Song N, Zhou X, Li D, Li X, Liu W Antimicrob Agents Chemother. 2022; 66(4):e0210521.
PMID: 35343782 PMC: 9017357. DOI: 10.1128/aac.02105-21.
Can We Improve Antifungal Susceptibility Testing?.
Durand C, Maubon D, Cornet M, Wang Y, Aldebert D, Garnaud C Front Cell Infect Microbiol. 2021; 11:720609.
PMID: 34568095 PMC: 8461061. DOI: 10.3389/fcimb.2021.720609.